Literature DB >> 6199043

Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.

J Kirchheimer, A Köller, B R Binder.   

Abstract

Plasminogen activators from prostate tissue were purified to apparent homogeneity by a procedure involving reverse ammonium sulfate gradient solubilization, chromatography on gelatine-Sepharose, gel filtration on Sephadex G-150, and chromatography on Con A-Sepharose as a final step. Two activators were obtained. The predominant one exhibited physicochemical, immunochemical and functional properties indistinguishable from human urinary high molecular weight urokinase. The other one, which amounted to about 20% was immunochemically related to tissue type plasminogen activator and its plasminogen activator activity was enhanced by addition of CNBr-fibrinogen fragments in a similar pattern as for the vascular plasminogen activator. The molecular weight, however, and enzymatic activities on the synthetic low molecular weight paranitroanilide substrates pyro-Glu-Gly-Arg-pNA and H-D-Ile-Pro-Arg-pNA were different to vascular plasminogen activator but similar to high molecular weight urinary urokinase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199043     DOI: 10.1016/0304-4165(84)90129-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.

Authors:  M Plebani; L Herszènyi; P Carraro; M De Paoli; G Roveroni; R Cardin; Z Tulassay; R Naccarato; F Farinati
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

Review 2.  Spinal cord compression in prostate cancer.

Authors:  J L Osborn; R H Getzenberg; D L Trump
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Coagulopathy in the prostate cancer patient: prevalence and clinical relevance.

Authors:  A S Adamson; J L Francis; R O Witherow; M E Snell
Journal:  Ann R Coll Surg Engl       Date:  1993-03       Impact factor: 1.891

Review 4.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

5.  Prognostic role of urokinase-type plasminogen activator in human gliomas.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

6.  Inactivation of human tumor cell pro-urokinase by granulocyte elastase.

Authors:  N Kanayama; T Terao
Journal:  Jpn J Cancer Res       Date:  1990-10

7.  Kinin-generating cascade in advanced cancer patients and in vitro study.

Authors:  Y Matsumura; K Maruo; M Kimura; T Yamamoto; T Konno; H Maeda
Journal:  Jpn J Cancer Res       Date:  1991-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.